EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

The Effects of Bifidobacterium Probiotic Supplementation on Blood Glucose: A Systematic Review and Meta-Analysis of Animal Models and Clinical Evidence

Emily P Van Syoc, Janhavi Damani, Zachary DiMattia, Erika Ganda, Connie J Rogers

Advances in Nutrition · 2024-01 · 15 (1) · 100137

DOI: 10.1016/j.advnut.2023.10.009 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Advances in Nutrition, 2024-01. Verfasst von Emily P Van Syoc und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dual-Title Ph.D Program in Integrative & Biomedical Physiology and Clinical & Translational Science, The Pennsylvania State University, University Pa…. Hauptthemen laut MEDLINE: Probiotics, Metabolic Syndrome, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, USDA, National Institute of Food and Agriculture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Probiotic supplementation is a potential therapeutic for metabolic diseases, including obesity, metabolic syndrome (MetS), and type 2 diabetes (T2D), but most studies deliver multiple species of bacteria in addition to prebiotics or oral pharmaceuticals. This may contribute to conflicting evidence in existing meta-analyses of probiotics in these populations and warrants a systematic review of the literature to assess the contribution of a single probiotic genus to better understand the contribution of individual probiotics to modulate blood glucose. We conducted a systematic review and meta-analysis of animal studies and human randomized controlled trials (RCTs) to assess the effects of Bifidobacterium (BF) probiotic supplementation on markers of glycemia. In a meta-analysis of 6 RCTs, BF supplementation had no effect on fasting blood glucose {FBG; mean difference [MD] = -1.99 mg/dL [95% confidence interval (CI): -4.84, 0.86], P = 0.13}, and there were no subgroup differences between subjects with elevated FBG concentrations and normoglycemia. However, BF supplementation reduced FBG concentrations in a meta-analysis comprised of studies utilizing animal models of obesity, MetS, or T2D [n = 16; MD = -36.11 mg/dL (CI: -49.04, -23.18), P < 0.0001]. Translational gaps from animal to human trials include paucity of research in female animals, BF supplementation in subjects that were normoglycemic, and lack of methodologic reporting regarding probiotic viability and stability. More research is necessary to assess the effects of BF supplementation in human subjects with elevated FBG concentrations. Overall, there was consistent evidence of the efficacy of BF probiotics to reduce elevated FBG concentrations in animal models but not clinical trials, suggesting that BF alone may have minimal effects on glycemic control, may be more effective when combined with multiple probiotic species, or may be more effective in conditions of hyperglycemia rather than elevated FBG concentrations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsMetabolic SyndromeDiabetes Mellitus, Type 2FemaleHumansAnimalsBlood GlucoseBifidobacteriumObesityModels, Animal

Stichwörter der Autor:innen

Bifidobacteriumblood glucosehemoglobin A1cmetabolic syndromeprobioticstype 2 diabetes mellitus

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Dual-Title Ph.D Program in Integrative & Biomedical Physiology and Clinical & Translational Science, The Pennsylvania State University, University Park, PA, United States; Department of Animal Science, The Pennsylvania…
  • The Intercollege Graduate Degree Program in Integrative and Biomedical Physiology, Huck Institutes of Life Sciences, The Pennsylvania State University, University Park, PA, United States.
  • Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA, United States.
  • Department of Animal Science, The Pennsylvania State University, University Park, PA, United States; The One Health Microbiome Center, The Pennsylvania State University, University Park, PA, United States.
  • Department of Nutritional Sciences, University of Georgia, Athens, GA, United States. Electronic address: crogers.nutrition@uga.edu.

Förderung

  • NCATS NIH HHS
  • USDA
  • National Institute of Food and Agriculture
  • National Center for Advancing Translational Sciences
  • National Institutes of Health

Zitieren

APA

Van Syoc, E. P., Damani, J., DiMattia, Z., Ganda, E., & Rogers, C. J. (2024). The Effects of Bifidobacterium Probiotic Supplementation on Blood Glucose: A Systematic Review and Meta-Analysis of Animal Models and Clinical Evidence. Advances in Nutrition, 15(1), 100137. https://doi.org/10.1016/j.advnut.2023.10.009

Vancouver

Van Syoc EP, Damani J, DiMattia Z, Ganda E, Rogers CJ. The Effects of Bifidobacterium Probiotic Supplementation on Blood Glucose: A Systematic Review and Meta-Analysis of Animal Models and Clinical Evidence. Advances in Nutrition. 2024;15(1):100137. doi:10.1016/j.advnut.2023.10.009

BibTeX
@article{VanSyoc2024,
  author = {Van Syoc, Emily P and Damani, Janhavi and DiMattia, Zachary and Ganda, Erika and Rogers, Connie J},
  title = {The Effects of Bifidobacterium Probiotic Supplementation on Blood Glucose: A Systematic Review and Meta-Analysis of Animal Models and Clinical Evidence},
  journal = {Advances in Nutrition},
  year = {2024},
  volume = {15},
  number = {1},
  pages = {100137},
  doi = {10.1016/j.advnut.2023.10.009}
}
Kostenlos starten →